These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 18473815

  • 1. Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
    Stratta P, Canavese C, Aime S.
    Curr Med Chem; 2008; 15(12):1229-35. PubMed ID: 18473815
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging].
    Giersig C.
    Radiologe; 2007 Sep; 47(9):794-9. PubMed ID: 17713753
    [Abstract] [Full Text] [Related]

  • 5. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
    Bongartz G.
    MAGMA; 2007 Apr; 20(2):57-62. PubMed ID: 17436028
    [Abstract] [Full Text] [Related]

  • 6. [Nephrogenic systemic fibrosis].
    Samtleben W.
    Radiologe; 2007 Sep; 47(9):778-84. PubMed ID: 17717643
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST, Simpson K, Roditi GH.
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD.
    AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
    [Abstract] [Full Text] [Related]

  • 9. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gadolinium and nephrogenic systemic fibrosis.
    Grobner T, Prischl FC.
    Kidney Int; 2007 Aug; 72(3):260-4. PubMed ID: 17507905
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Aug; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
    Bhave G, Lewis JB, Chang SS.
    J Urol; 2008 Sep; 180(3):830-5; discussion 835. PubMed ID: 18635232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.